Vaccines for Mycoplasma Diseases in Animals and Man

Journal of Comparative Pathology

Volumn 140, Issue 2-3, 2009, Pages 85-96

  Nicholas, R A J ^a   Ayling, R D ^a   McAuliffe, L ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

cattle; goat; Mycoplasma spp.; mycoplasmosis; pig; pneumonia; poultry; review; sheep; vaccines

Indexed keywords

AGLOVAX; BACTERIAL VACCINE; DNA VACCINE; INACTIVATED VACCINE; LIVE VACCINE; MYCOPLASMA VACCINE; RECOMBINANT VACCINE; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

AGALACTIA; ANIMAL DISEASE; ARTHRITIS; BACTERIAL STRAIN; BACTERIUM MUTANT; CONTAGIOUS PLEUROPNEUMONIA; COW; DISEASE EXACERBATION; DISEASE SEVERITY; GRAM NEGATIVE INFECTION; HUMAN; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFECTION RISK; MASTITIS; MYCOPLASMA; NONHUMAN; PNEUMONIA; POULTRY; PRIORITY JOURNAL; PROTECTION; RESPIRATORY TRACT DISEASE; REVIEW; SWINE; SYNOVITIS; TEMPERATURE; VACCINATION;

ANIMALS; BACTERIAL VACCINES; HUMANS; MYCOPLASMA; MYCOPLASMA INFECTIONS;

ANIMALIA; BOS; BOVINAE; CAPRA; CAPRA HIRCUS; MYCOPLASMA; MYCOPLASMA BOVIS; OVIS ARIES; SUIDAE; SUS;

EID: 60649091477     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2008.08.004     Document Type: Review

References (89)

1. Abdo E.M., Nicolet J., and Frey J. Antigenic and genetic characterization of lipoprotein LppQ from Mycoplasma mycoides subsp. mycoides SC. Clinical and Diagnostic Laboratory Immunology 7 (2000) 588-595
2. Abusugra I., Wolf G., Bölske G., Thiaucourt F., and Morein B. ISCOM vaccine against contagious bovine pleuropneumonia (CBPP) 1. Biochemical and immunological characterization. Veterinary Immunology and Immunopathology 59 (1997) 31-48
3. Agrimi U., Ru G., Cardone F., Pocchiari M., and Caramelli M. Epidemic of transmissible spongiform encephalopathy in sheep and goats in Italy. Lancet 353 (1999) 560-561
4. Armstrong C.H., Scheidt A.B., Thacker H.L., Runnels L.J., and Freeman M.J. Porcine mycoplasmas. In: Whitford H.W., Rosenbusch R.F., and Lauerman L.H. (Eds). Mycoplasmosis in Animals: Laboratory Diagnosis (1984), Iowa State University Press, Ames, Iowa 68-83
5. Ayling R.D., Baker S.E., Peek M.L., Simon A.J., and Nicholas R.A.J. Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against Mycoplasma bovis. Veterinary Record 146 (2000) 745-747
6. Ayling R.D., and Nicholas R.A.J. Mycoplasma respiratory infections. In: Aitken I.D. (Ed). Sheep Diseases. 4th Edit. (2007), Blackwell Publishing, Oxford 231-235
7. Barile M.F. Immunization against Mycoplasma pneumoniae disease: a review. Israel Journal of Medical Sciences 20 (1988) 912-915
8. Barile M.F., Chandler D.K., Yoshida H., Grabowski M.W., and Razin S. Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines. Infection and Immunity 56 (1985) 2450-2457
9. Bar-Moshe B., Rapapport E., and Brenner J. Vaccination trials against Mycoplasma mycoides subsp. mycoides (large-colony type) infection in goats. Israel Journal of Medical Sciences 20 (1984) 972-974
10. Barry M.A., Lai W.C., and Johnston S.A. Protection against mycoplasma infection using expression-library immunization. Nature 377 (1995) 632-635
11. Bastian F., Sanders D., and Forbes W. Spiroplasma spp. from TSE brains or ticks induce spongiform encephalopathy. Journal of Medical Microbiology 56 (2007) 1235-1242
12. Bergonier D., Bertholet X., and Poumarat F. Contagious agalactia of small ruminants: current knowledge concerning epidemiology, diagnosis and control. Revue Scientifique et Technique (Office International des Épizooties) 16 (1997) 848-873
13. Blancou J. Early methods of surveillance and control for contagious bovine pleuropneumonia. Revue Scientifique et Technique (Office International des Épizooties) 15 (1996) 1263-1282
14. Bryson T.D.G., Ball H.J., Foster F., and Brice N. Enhanced severity of induced Mycoplasma bovis pneumonia in calves following immunization with different antigenic extracts. Research in Veterinary Science 72 Suppl. A (2002) 19
15. Chen A.Y., Fry S.R., Forbes-Faulkner J., Daggard G.E., and Mukkur T.K. Comparative immunogenicity of Mycoplasma hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice. Veterinary Microbiology 114 (2006) 252-259
16. Chen Y.L., Wang S.N., Yang W.J., Chen Y.J., Lin H.H., and Shiuan D. Expression and immunogenicity of Mycoplasma hyopneumoniae heat shock protein antigen P42 by DNA vaccination. Infection and Immunity 71 (2003) 1155-1160
17. Cimolai N., Cheong A.C., Morrison B.J., and Taylor G.P. Mycoplasma pneumoniae reinfection and vaccination: protective oral vaccination and harmful immunoreactivity after re-infection and parenteral immunization. Vaccine 14 (1996) 1479-1483
18. Conceição F.R., Michelon A., Michelon M., de Cerqueira G., and Dellagostin O.A. LTB-R1: an alternative to swine mycoplasmal pneumonia control. Brazilian Journal of Microbiology 34 Suppl. 1 (2003) 179-181
19. Couch R.B., Cate T.R., and Chanock R.M. Infection with artificially propagated Eaton agent (Mycoplasma pneumoniae). Implications for development of attenuated vaccine for cold agglutinin-positive pneumonia. Journal of the American Veterinary Medical Association 187 (1964) 442-447
20. Dawson A., Harvey R.E., Thevasagayam S.J., Sherington J., and Peters A.R. Studies of the field efficacy and safety of a single-dose Mycoplasma hyopneumoniae vaccine for pigs. Veterinary Record 151 (2002) 535-538
21. Dedieu-Engelman L. Contagious bovine pleuropneumonia: a rationale for the development of a mucosal sub-unit vaccine. Comparative Immunology, Microbiology and Infectious Diseases 31 (2007) 227-238
22. Egwu G., Nicholas R.A.J., Ameh J.A., and Bashiruddin J.B. Contagious bovine pleuropneumonia: an update. Veterinary Bulletin 66 (1996) 195-208
23. Fagan P.K., Djordjevic S.P., Eamens G.J., Chin J., and Walker M.J. Molecular characterization of a ribonucleotide reductase (nrdF) gene fragment of Mycoplasma hyopneumoniae and assessment of the recombinant product as an experimental vaccine for enzootic pneumonia. Infection and Immunity 64 (1996) 1060-1064
24. Feberwee A., Landman W.J., Banniseht-Wysmuller T., Klinkenberg D., Vernooij J.C., Gielkens A.L., and Stegeman J.A.T. The effect of a live vaccine on the horizontal transmission of Mycoplasma gallisepticum. Avian Pathology 35 (2006) 359-366
25. Friis N.F., Kokotovic B., and Svensmark B. Mycoplasma hyorhinis isolation from cases of otitis media in piglets. Acta Veterinaria Scandinavica 43 (2002) 191-193
26. Garba S.A., Ajayi A., Challa L.D., Bello M.K., Gazama J.N., Gimba H., et al. Field trial of inactivated oil-adjuvant Gladysdale strain vaccine for contagious bovine pleuropneumonia. Veterinary Record 119 (1986) 376-377
27. George-Chandy A., Eriksson K., Lebens M., Nordstrom I., Schon E., and Holmgren J. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infection and Immunity 69 (2001) 5716-5725
28. Gil M.C., Hermosa De Mendoza M., Rey J.J., Alonso M., Poveda J.B., and Hermosa De Mendoza J. Aetiology of caprine contagious agalactia syndrome in Extramudura, Spain. Veterinary Record 144 (1999) 24-25
29. Gois M., and Kuksa F. Intranasal infection of gnotobiotic piglets with Mycoplasma hyorhinis: differences in virulence of the strains and influence of age on the development of infection. Zentralblatt für Veterinarmedizin, Reihe B 5 (1974) 352-361
30. Gray M.A., Simam P., and Smith G.R. Observations on experimental inactivated vaccines for CBPP. Journal of Hygiene 97 (1986) 305-315
31. Greco G., Corrente M., Buonovoglia D., Aliberti A., and Fasanella A. Inactivated vaccine induces protection against Mycoplasma agalactiae infection in sheep. Microbiologica 25 (2002) 17-20
32. Haesebrouck F., Pasmans F., Chiers K., Maes D., Ducatelle R., and Decostere A. Efficacy of vaccines against bacterial diseases in swine: what can we expect?. Veterinary Microbiology 100 (2004) 255-268
33. Holmgren J., Lycke N., and Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 12 (1993) 1179-1184
34. Howard C.J., Stott E.J., Thomas L.H., Gourlay R.N., and Taylor G. Protection against respiratory disease in calves induced by vaccines containing respiratory syncytial virus, parinfluenza type 3 virus, Mycoplasma bovis and M. dispar. Veterinary Record 121 (1987) 372-376
35. Hübschle O.J.B., Tjipura-Zaire G., Abusugra I., di Francesca G., Mettler F., Pini A., and Morein B. Experimental field trial with an immunostimulating complex (ISCOM) vaccine against contagious bovine pleuropneumonia. Journal of Veterinary Medicine, Series B 50 (2003) 298-303
36. Hudson, J. R. (1971). Contagious Bovine Pleuropneumonia. FAO Agricultural Studies, 86, Rome.
37. Jacobs E., Stuhlert A., Drews M., Pumpe K., Schaefer H.E., Kist M., and Bredt W. Host reactions to Mycoplasma pneumoniae infections in guinea-pigs preimmunized systemically with the adhesin of this pathogen. Microbial Pathogenesis 5 (1988) 259-265
38. Javed M.A., Frasca S., Rood D., Cecchini K., Gladd M., Geary S.J., and Silbart L.K. Correlates of immune protection in chickens vaccinated with Mycoplasma gallisepticum strain GT5 following challenge with pathogenic M. gallisepticum strain R(low). Infection and Immunity 73 (2005) 5410-5419
39. Johnson S., Sidebottom D., Bruckner F., and Collins D. Identification of Mycoplasma fermentans in synovial fluid samples from arthritis patients with inflammatory disease. Journal of Clinical Microbiology 38 (2000) 90-93
40. Jones J.F., Whithear K.G., Scott P.C., and Noormohammadi A.H. Duration of immunity with Mycoplasma synoviae: comparison of the live attenuated vaccine MS-H (Vaxsafe MS) with its wild-type parent strain, 86079/7NS. Avian Diseases 50 (2006) 228-231
41. 2. Veterinary Research Communications 29 (2005) 181-188
42. Lai W.C., Bennett M., Pakes S.P., and Murphree S.S. Potential subunit vaccine against Mycoplasma pulmonis purified by a protective monoclonal antibody. Vaccine 3 (1991) 177-184
43. Lai W.C., Pakes S.P., Ren K., Lu Y.S., and Bennett M. Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis. Journal of Immunology 158 (1997) 2513-2516
44. Leon Vizcaino L., Garrido Abellan F., Cubero Pablo M.J., and Perales A. Immunoprophylaxis of caprine contagious agalactia due to Mycoplasma agalactiae with an inactivated vaccine. Veterinary Record 137 (1995) 266-269
45. Lin J.H., Chen S.P., Yeh K.S., and Weng C.N. Mycoplasma hyorhinis in Taiwan: diagnosis and isolation of swine pneumonia pathogen. Veterinary Microbiology 115 (2006) 111-116
46. Lorenzon S., David A., Nadew M., Wesonga H., and Thiaucourt F. Specific PCR identification of the T1 vaccine strains for contagious bovine pleuropneumonia. Molecular and Cellular Probes 14 (2000) 205-210
47. MacOwan K.J., and Minette J.E. A mycoplasma from acute contagious caprine pleuropneumonia in Kenya. Tropical Animal Health and Production 8 (1976) 91-95
48. MacOwan K.J., and Minette J.E. The effect of high passage mycoplasma strain F38 on the course of contagious caprine pleuropneumonia (CCPP). Tropical Animal Health and Production 10 (1978) 31-35
49. McAuliffe L., Ayling R.D., Hatchel F.M., King A.I.M., and Nicholas R.A.J. The detection of Mycoplasma ovipneumoniae in pasteurella vaccinated sheep flocks with respiratory disease in England. Veterinary Record 153 (2003) 687-688
50. McAuliffe L., Ellis R., Lawes J., Ayling R.D., and Nicholas R.A.J. 16S rDNA and DGGE: a single generic test for detecting and differentiating Mycoplasma species. Journal of Medical Microbiology 54 (2005) 1-9
51. McMartin D.A., MacOwan K.J., and Swift L.L. A century of classical contagious pleuropneumonia: from original description to aetiology. British Veterinary Journal 136 (1980) 507-515
52. March J.B. Improved formulations for existing CBPP vaccines - recommendations for change. Vaccine 22 (2004) 4358-4364
53. March J.B., Jones G.E., Williamson H.S., and Amanfu W. Studies on the immunological diversity of type, vaccine and wild strains of Mycoplasma mycoides subsp. mycoides SC. In: Stipkovits L., Rosengarten R., and Frey J. (Eds). Mycoplasmas of Ruminants: Pathogenicity, Diagnostics, Epidemiology and Molecular Genetics Vol. 3 (1999), Office for Official Publications of the European Communities, Luxembourg 159-162
54. March J.B., Jepson C.D., Clark J.R., Totsika M., and Calcutt M.J. Phage library screening for the rapid identification and in vivo testing of candidate genes for a DNA Vaccine against Mycoplasma mycoides subsp. mycoides small colony biotype. Infection and Immunity 74 (2006) 167-174
55. Markham J.F., Morrow C.J., Scott P.C., and Whithear K.G. Safety of a temperature-sensitive clone of Mycoplasma synoviae as a live vaccine. Avian Diseases 42 (1998) 677-681
56. Markham J.F., Morrow C.J., and Whithear K.G. Efficacy of a temperature-sensitive Mycoplasma synoviae live vaccine. Avian Diseases 42 (1998) 671-676
57. Masiga, W., Rossiter, P. and Bessin, R. (1998). Contagious bovine pleuropneumonia. I. Epidemiology: the present situation in Africa and epidemiological trends. In: Proceedings of the FAO/OIE/OAU Consultative Group Meeting, Rome, pp. 43-48.
58. Moore R.J., Lenghaus C., Sheedy S.A., and Doran T.J. Improved vectors for expression library immunization - application to Mycoplasma hyopneumoniae infection in pigs. Vaccine 20 (2001) 115-120
59. Morita T., Fukuda H., Awakura T., Shimada A., Umemura T., Kazama S., and Yagihashi T. Demonstration of Mycoplasma hyorhinis as a possible primary pathogen for porcine otitis media. Veterinary Pathology 32 (1995) 107-111
60. Mulira G.L., and Saunders J.R. Immune response of heifers to vaginal submucosal or subcutaneous vaccination and intravaginal challenge with Ureaplasma diversum. Canadian Journal of Veterinary Research 58 (1994) 109-113
61. Nicholas R.A.J., Ayling R.D., Houlihan M., and Woodger N. Mycoplasma of adult cattle: bugs worth bothering with?. Irish Veterinary Journal 59 (2006) 301-304
62. Nicholas R.A.J., Ayling R.D., and Stipkovits L. An experimental vaccine for calf pneumonia caused by Mycoplasma bovis. Vaccine 20 (2002) 3569-3575
63. Nicholas, R. A. J., Tjipura-Zaire, G., Scacchia, M., Frey, J. and Hübschle, O. J. B. (2004). An inactivated vaccine against CBPP exacerbates disease in cattle. In: Proceedings of FAO/OIE/AU Consultative meeting, Rome, pp. 91-97.
64. Noormohammadi A.H., Jones J.F., Harrigan K.E., and Whithear K.G. Evaluation of the non-temperature-sensitive field clonal isolates of the Mycoplasma synoviae vaccine strain MS-H. Avian Diseases 47 (2003) 355-360
65. OIE. Contagious caprine pleuropneumonia. Manual of Standards for Diagnostic Tests and Vaccines (2004), Office International des Epizooties, Paris 503-514
66. Papazisi L., Frasca Jr. S., Gladd M., Liao X., Yogev D., and Geary S.J. GapA and CrmA coexpression is essential for Mycoplasma gallisepticum cytadherence and virulence. Infection and Immunity 70 (2002) 6839-6845
67. Pepin M., Sanchis R., Abadie G., Lambert M., Dufour P., and Guibert J.M. Experimental vaccination against Mycoplasma agalactiae using an inactivated vaccine. In: Poveda J.B., Fernandez A., Frey J., and Johansson K.-E. (Eds). Mycoplasmas of Ruminants: Pathogenicity, Diagnostics, Epidemiology and Molecular Genetics Vol. 5 (2001), European Commission, Brussels 162-165
68. Pizza M., Giuliani M.M., Fontana M.R., Monaci E., Douce G., Dougan G., et al. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19 (2001) 2534-2541
69. Pommier P., Keita A., Pagot E., and Flochlay A. Field efficacy of a Mycoplasma hyopneumoniae vaccine in control of enzootic pneumonia in swine. Revue de Médecine Vétérinaire 151 (2000) 835-840
70. Poumarat F., Belli P., and Calavalas D. Immunoprophylaxis of experimental Mycoplasma bovis arthritis in calves. In: Bergonier D., Berthelot X., and Frey J. (Eds). Mycoplasmas of Ruminants: Pathogenicity, Diagnostics, Epidemiology and Molecular Genetics Vol. 4 (2000), European Commission, Brussels, Belgium 75-78
71. Ramirez A.S., De la Fe C., Assuncao P., Gonzalez M., and Poveda J.B. Preparation and evaluation of an inactivated polyvalent vaccine against Mycoplasma spp. on infected goats. In: Poveda J.B., Fernandez A., Frey J., and Johansson K.-E. (Eds). Mycoplasmas of Ruminants: Pathogenicity, Diagnostics, Epidemiology and Molecular Genetics Vol. 5 (2001), European Commission, Brussels, Belgium 154-157
72. Ross R.F. Mycoplasma-animal pathogens. In: Kahane I., and Adoni J.R.A. (Eds). Rapid Diagnosis of Mycoplasmas (1993), Plenum Press, New York 69-109
73. Rurangirwa F.R., Masiga W.M., and Muthomi E.K. Immunisation of goats against contagious caprine pleuropneumonia using sonicated antigens of F-38 strain of mycoplasma. Research in Veterinary Science 36 (1984) 174-176
74. Rurangirwa F.R., McGuire T.C., Kibor A., and Chema S. An inactivated vaccine for contagious caprine pleuropneumonia. Veterinary Record 121 (1987) 397-400
75. Santona A., Carta F., Fraghi P., and Turrini F. Mapping antigenic sites of an immunodominant surface lipoprotein of Mycoplasma agalactiae, AvgC, with the use of synthetic peptides. Infection and Immunity 70 (2002) 171-176
76. Shin J.H., Joo H.S., Lee W.H., Seok H.B., Calsamig M., Pijoan C., and Molitor T.W. Identification and characterization of cytopathogenic Mycoplasma hyorhinis from swine farms with a history of abortions. Journal of Veterinary Medical Science 65 (2003) 501-509
77. Smith C.B., Friedewald W.T., and Chanock R.M. Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers. Journal of the American Medical Association 199 (1967) 353-358
78. Sunder J., Srivastava N.C., and Singh V.P. Preliminary trials on the development of vaccine against Mycoplasma mycoides subsp. mycoides LC infection in goats. Journal of Applied Animal Research 21 (2002) 75-80
79. Tadjbakhsh H. Traditional methods used for controlling animal diseases in Iran. Revue Scientifique et Technique (Office International des Épizooties) 13 (1994) 810-815
80. Tola S., Manunta D., Rocca S., Rocchiagiani A.M., Idini G., Angioi P.P., and Leori G. Experimental vaccination against Mycoplasma agalactiae using different inactivated vaccines. Vaccine 17 (1999) 2764-2768
81. Tulasne J.J., Litamoi J.K., Morein B., Dedieu L., Palya V.J., Yami M., et al. Contagious bovine pleuropneumonia vaccines: the current situation and the need for improvement. Revue Scientifique et Technique (Office International des Épizooties) 15 (1996) 1373-1396
82. Turkaslan J. Control of important mycoplasma diseases in Turkey with special emphasis on CCPP and contagious agalactia. IOM Letters 1 (1990) 184-185
83. Urbaneck D., Leibig F., Forbrig T.H., and Stache B. Erfahrungsbericht zur Anwedung bestandsspezifischer impfstoffe gegen respiratorische infektionen mit beteiligung von Mykoplasma bovis in einem mastrindergrossbestand. Der Praktische Tierarzt 81 (2000) 756-763
84. Waite E.R., and March J.B. Capsular polysaccharide conjugate vaccines against contagious bovine pleuropneumonia: immune responses and protection in mice. Journal of Comparative Pathology 126 (2002) 171-182
85. Waites K.B., and Talkington D.F. Mycoplasma pneumoniae and its role as a human pathogen. Clinical Microbiological Reviews 17 (2004) 697-728
86. Whithear K.G. Control of avian mycoplasmoses by vaccination. Revue Scientifique et Technique (Office International des Épizooties) 15 (1996) 1527-1553
87. Wikstrom A., and Jensen J.S. Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sexually Transmitted Infections 82 (2006) 276-279
88. Yagihashi T., and Tajima M. Antibody responses in sera and respiratory secretions from chickens infected with Mycoplasma gallisepticum. Avian Diseases 30 (1986) 543-550
89. Yayoshi M., Araake M., Hayatsu E., Takezawa T., and Yoshioka M. Immunogenicity and protective effect of hemolysis mutants of Mycoplasma pneumoniae. Microbiology and Immunology 29 (1985) 1029-1037